Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To estimate the risk and prevalence of Mycobacterium tuberculosis (MTB) infection and tuberculosis (TB) incidence, prevalence, and mortality, including disease attributable to human immunodeficiency virus (HIV), for 212 countries in 1997. PARTICIPANTS: A panel of 86 TB experts and epidemiologists from more than 40 countries was chosen by the World Health Organization (WHO), with final agreement being reached between country experts and WHO staff. EVIDENCE: Incidence of TB and mortality in each country was determined by (1) case notification to the WHO, (2) annual risk of infection data from tuberculin surveys, and (3) data on prevalence of smear-positive pulmonary disease from prevalence surveys. Estimates derived from relatively poor data were strongly influenced by panel member opinion. Objective estimates were derived from high-quality data collected recently by approved procedures. CONSENSUS PROCESS: Agreement was reached by (1) participants reviewing methods and data and making provisional estimates in closed workshops held at WHO's 6 regional offices, (2) principal authors refining estimates using standard methods and all available data, and (3) country experts reviewing and adjusting these estimates and reaching final agreement with WHO staff. CONCLUSIONS: In 1997, new cases of TB totaled an estimated 7.96 million (range, 6.3 million-11.1 million), including 3.52 million (2.8 million-4.9 million) cases (44%) of infectious pulmonary disease (smear-positive), and there were 16.2 million (12.1 million-22.5 million) existing cases of disease. An estimated 1.87 million (1.4 million-2.8 million) people died of TB and the global case fatality rate was 23% but exceeded 50% in some African countries with high HIV rates. Global prevalence of MTB infection was 32% (1.86 billion people). Eighty percent of all incident TB cases were found in 22 countries, with more than half the cases occurring in 5 Southeast Asian countries. Nine of 10 countries with the highest incidence rates per capita were in Africa. Prevalence of MTB/HIV coinfection worldwide was 0.18% and 640000 incident TB cases (8%) had HIV infection. The global burden of tuberculosis remains enormous, mainly because of poor control in Southeast Asia, sub-Saharan Africa, and eastern Europe, and because of high rates of M tuberculosis and HIV coinfection in some African countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disease Control Priorities in Developing Countries
Mosley, W. H. (1993) · World Bank, Washington, DC eBooks · doi:10.1596/0-1952-0990-7 · Cited by 1,400
Global Tuberculosis Control 2011, WHO Report 2011
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,022
Global tuberculosis incidence and mortality during 1990-2000.
Dolin, P., Raviglione, M. C., & Kochi, A. (1994) · Europe PMC (PubMed Central) · Cited by 877
Self-citationEdlin, B. R., Tokars, J. I., Grieco, M. H., Crawford, J. T., Williams, J., Sordillo, E. M., Ong, K. R., Kilburn, J. O., Dooley, S. W., Castro, K. G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206043262302 · Cited by 861
Tuberculosis: a global overview of the situation today.
Sudre, P., ten Dam, G., & Kochi, A. (1992) · Europe PMC (PubMed Central) · Cited by 539
Prospects for worldwide tuberculosis control under the WHO DOTS strategy
Dye, C., Garnett, G. P., Sleeman, K., & Williams, B. G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03199-7 · Cited by 462
Self-citationWorld Development Report 1992.
Bank, W. (1992) · Population and Development Review · doi:10.2307/1973669 · Cited by 354
(1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470110027006 · Cited by 272
Coronado, V. G., Beck-Sague, C. M., Hutton, M. D., Davis, B. J., Nicholas, P., Villareal, C., Woodley, C. L., Kilburn, J. O., Crawford, J. T., Frieden, T. R., et al. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/168.4.1052 · Cited by 200
Tuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade
Shafer, R. W., & Edlin, B. R. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.4.683 · Cited by 174
Tuberculosis and HIV: current status in Africa.
Raviglione, M. C., Harries, A. D., Msiska, R., Wilkinson, D., & Nunn, P. (1997) · PubMed · Cited by 162
Self-citationMethodological issues in the estimation of the tuberculosis problem from tuberculin surveys
Rieder, H. L. (1995) · Tubercle and Lung Disease · doi:10.1016/0962-8479(95)90552-9 · Cited by 152
World Health Statistics Annual, 1995.
(1997) · Biometrics · doi:10.2307/2533537 · Cited by 143
[Epidemiology of tuberculosis].
Durieux, P. (1990) · PubMed · Cited by 103
Datta, M., Radhamani, M. P., Selvaraj, R., et al. (1993) · Tubercle and Lung Disease · doi:10.1016/0962-8479(93)90008-l · Cited by 87
Githui, W. A., Nunn, P., Juma, E., Karimi, F., Brindle, R., Kamunyi, R., Gathua, S., Gicheha, C. M., Morris, J., & Omwega, M. J. (1992) · Tubercle and Lung Disease · doi:10.1016/0962-8479(92)90087-z · Cited by 83
Broek, J. V. D., Mfinanga, S., Moshiro, C. S., O'Brien, R., Mugomela, A., & Lefi, M. (1998) · PubMed · Cited by 65
Espinal, M., Reingold, A. L., Perez, G. T. L., Pantaleón, E. C., Soto, S., Cruz, E., Matos, N., & Gloria González, G. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199610010-00006 · Cited by 26
Die Fälle von Lungentuberkulose in der aargauischen Heilstätte Barmelweid aus den Jahren 1912–1927
Krebs, W. (1930) · Lung · doi:10.1007/bf02081494 · Cited by 16
Post-Sanatorium Tuberculosis Survival Rates in Minnesota
Hilleboe, H. E. (1941) · Public Health Reports (1896-1970) · doi:10.2307/4583713 · Cited by 7
Cited by
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Self-citationGutierrez, M. G., Master, S. S., Singh, S. B., Taylor, G. A., Colombo, M. I., & Deretic, V. (2004) · Cell · doi:10.1016/j.cell.2004.11.038 · Cited by 2,252
“…but some critical points have been man pathogen infecting over a billion people worldwide uncovered: (1) the starvation-initiated signaling results (Dye et al., 1999), is based on its ability to parasitize in the inhibition of Tor, which, by still unknown downhost macrophages (Russell et al.,…”
BackgroundThe Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
Houben, R. M. G. J., & Dodd, P. J. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002152 · Cited by 2,054
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
Metadata
- Authors
- Dye, C., Scheele, S., >Dolin, P., Pathania, V., Raviglione, M. C., & for the WHO Global Surveillance and Monitoring Project
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1999-08-18
- Volume
- 282
- Issue
- 7
- Pages
- 677
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2157737997
- Cited by
- 2,947
- References
- 20
- FWCI
- 74.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.